Berkeley, CA, United States of America

Eva Raschke




Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2005

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Eva Raschke in Gene Regulation

Introduction: Eva Raschke is an innovative inventor based in Berkeley, California, who has made significant contributions to the field of gene expression. With her expertise in biotechnology, Raschke has developed cutting-edge methods that enhance our understanding of gene regulation, demonstrating the transformative power of scientific research.

Latest Patents: Eva Raschke holds an impressive patent titled "Modulation of gene expression using localization domains." This patent describes methods and compositions for regulating gene expression, particularly through the use of localization domains. The invention focuses on the creation of fusions between localization domains and DNA binding domains, along with optional regulatory domains, to achieve precise control of gene expression.

Career Highlights: Raschke is employed by Sangamo Biosciences, Inc., where she applies her knowledge and skills in the dynamic field of gene therapy and biotechnology. Her work at Sangamo is instrumental in advancing research in gene editing and cellular programming, underscoring her commitment to innovation in life sciences.

Collaborations: Throughout her career, Eva Raschke has collaborated with several esteemed colleagues, including Elizabeth J. Wolffe and Fyodor Urnov. These collaborations have allowed her to leverage diverse expertise, enhancing the impact of her research and broadening the scope of her inventions.

Conclusion: Eva Raschke stands out as a prominent inventor in the realm of gene regulation, with a noteworthy patent that has the potential to revolutionize our understanding and manipulation of gene expression. Her dedication to research and collaboration at Sangamo Biosciences establishes her as a key figure in the ongoing exploration of biotechnological advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…